Search Results 1341-1350 of 11359 for Ibrance
Mayo Clinic treats first person in the US with a novel radiopharmaceutical therapy for breast cancer. Researchers are leading the nation in using powerful ...
Efavirenz, emtricitabine, and tenofovir combination is used alone or with other anti-HIV medicines to treat human immunodeficiency virus (HIV) infection. HIV is ...
The purpose of this study is to study the length of the QTc interval in patients receiving the standard of care dose of intravenous droperidol for headache ...
ROCHESTER, Minn. — A new multicenter, international study suggests that people who have early-stage triple-negative breast cancer (TNBC) and high levels of ...
Cancer is caused by changes (mutations) to genes that control the way cells function. Tumors with high number of mutations may respond well to immunotherapy.
The purpose of this study is to evaluate the relative effects of three commonly used corticosteroids for the treatment of uveitic macular edema (swelling of the ...
Learn about our team of brain tumor doctors and surgeons who are researching new ways of diagnosing and treating this condition.
The purpose of this study is to evaluate the safety and effectiveness of venetoclax plus ibrutinib for participants with T-cell Prolymphocytic Leukemia (T-PLL) ...
Contact the IBD Biobank Study team at Mayo Clinic for more information about eligibility, participation, enrollment, costs or other questions.
Study evaluating if active irrigation by IRRAflow® with infusion of tPA will reduce the time needed for clearance of intracerebral and intraventricular ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.